FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

15524811000001107: Vascace 1mg tablets (Roche Products Ltd) 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
54950401000001113 Vascace 1mg tablets (Roche Products Ltd) 30 tablet (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
55006401000001116 Vascace 1mg tablets (Roche Products Ltd) 30 tablet 3 x 10 tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Is a Cilazapril 1mg tablets 30 tablet true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Has AMP Vascace 1mg tablets (Roche Products Ltd) true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Cilazapril true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Has specific active ingredient Cilazapril monohydrate false Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Has specific active ingredient Cilazapril monohydrate true Inferred relationship Existential restriction modifier
Vascace 1mg tablets (Roche Products Ltd) 30 tablet Has basis of strength substance Cilazapril true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start